Agenda

  1. Session 5: Choice of two break-out sessions
  2. Session 5A: Biocides topics overlapping with other legislation
  3.  

    Chair:

    Camelia Mihai Camelia Mihai
    Team Lead Biocides, Biocides For Europe, Cefic, Belgium
  4. Is my product a cosmetic, biocide, or both ? - assessment criteria for the borderline

    Gerald Renner Gerald Renner
    Director Technical Regulatory & International Affairs, Cosmetics Europe, Belgium
  5. Does the BPR promote innovations in disinfection?

    • Probiotics
    • Super-oxidised water
    • Re-formulated hydrogen peroxide 
    • Chemical leasing
    Manfred Klade Manfred Klade
    Environmental Engineer, Bureau for Chemical Engineering TB-Klade, Austria
  6. BPR and other legislative regimes

    • The legislators’ original intention
    • Legislative overlaps and conflicts
    • Classification and labelling
    • Treated articles
    • Impact for global industries:
      • a 'road to nowhere' or
      • a 'highway to hell'
    Koen Van Maldegem Koen Van Maldegem
    Partner, EU Regulatory, Fieldfisher LLP, Belgium
  7. Q&A

  8. Refreshments

  9. Moderators' feedback

  10. Session 6: Sustainability of biocides and circular economy
  11.  

    Chair:

    David Dillon David Dillon
    Independent Biocides Expert
  12. Efficacy assessment and sustainability

    • As little as possible – as much as necessary
    • The fear of bacteria and the ”precautionary principle”
    • A highly regulated market versus a consumer’s free choice
    • The quest for easy
    • Efficacy as necessary base for using a biocide
    • Beyond efficacy… (Efficacy necessary but not sufficient)
    Ulrike Frank Ulrike Frank
    Senior Scientific Officer, Swedish Chemicals Agency, Sweden
  13. New active substance, sustainable uses – the case for chlorine dioxide

    • Chlorine dioxide – a sustainable treatment alternative
    • Methods of generation – enough to cover everything?
    • An alternative delivery system (ex situ)
    • Case examples of sustainable uses
    Sjef Swinkels Sjef Swinkels
    European Market Development Manager Water Treatment, Brenntag Holding GmbH, Germany
  14. The contribution of biocides to sustainable economies

    • Benefits of biocides within the regulatory framework
    • Case examples of the value of biocides to sustainable economies
    • The past, the present and the future –a compelling need for change
    Ian Watt Ian Watt
    Regulatory Sciences and Product Sustainability, Microbial Control, DuPont Specialty Products Division, UK
  15. Silver leaching: A report on silver in sportswear

    Anders Finnson Anders Finnson
    Senior Environmental Advisor, Swedish Water and Waste Water Association, Sweden
  16. Q&A

  17. Lunch

  18. Session 6: Sustainability of biocides and circular economy continued
  19. Substitution of chemicals of concern – Promoting innovation by facilitating partnerships

    • The Europe Enterprise Network and the Partnership Opportunities Database (what they are, how they work)
    • Project’s objectives and what we have done
    • Market segments (companies’ needs and attitudes towards substitution, how to further support them and how to reach them)
    • Lessons from the biocidal product market
    Meg Postle Meg Postle
    Director, Risk & Policy Analysts Ltd/RPA Europe, Italy
  20. Not only biocides: a contribution from microbial-based systems for infection and antimicrobial resistance (AMR) control

    • Healthcare-associated infections are a global concern: persistent microbial contamination and AMR of pathogens are major causes
    • Microbial-based sanitation approaches can be very efficient in stably abating pathogens and their AMR
    • Results of our studies (published research)
    • Further innovations and future perspectives
    Elisabetta Caselli Elisabetta Caselli
    Associate Professor of Clinical Microbiology, Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Italy
  21. Panel with Q&A

    • What does sustainable use of biocides entail?
    • What is the role of biocides in a circular economy?
    • How to define a workable regulatory framework for substitution of substances?
  22. Refreshments

  23. Session 7: Testing and modelling
  24. Guidance development overview from German efficacy expert

    Juliane Fischer Juliane Fischer
    Scientific Officer, German Environment Agency, Germany
  25. Impact of substance ID on read-across, data sharing and testing, and its strategic implication for registrations

    • Background to substance identity (focus on UVCB substances)
    • Interplay between REACH, BPR and PPP Regulations – how to ensure consistency of approach
    • How should UVCB substances be named and identified under the BPR and who should be involved
    • Redefinition of active substances
    • The balance between unnecessary animal testing and correct hazard assessment
      • source versus composition-based naming
      • narrow substance definition versus broad substance definition
    • The grey area of when two compositions are the same or not – substance sameness
    • What to do when substance id/substance definition causes practical problems for data sharing under biocides
    Steve Buchanan Steve Buchanan
    Senior Chemistry & REACH Consultant, TSG Consulting, UK
  26. Recent developments and technical issues with the testing of in situ generated active substances and products

    • Background around in-situ actives and the BPR
    • Overview of current guidance on data requirements
    • Technical issues faced by in-situ actives
    Emma Miller Emma Miller
    Managing Chemistry Consultant, Yordas Group, UK
  27. Q&A session

  28. Close of conference